Get my own profile
Public access
View all174 articles
41 articles
available
not available
Based on funding mandates
Co-authors
Jurgen RehmSenior Scientist, Centre for Addiction and Mental HealthVerified email at camh.net
Tony P GeorgeProfessor of Psychiatry, University of Toronto; Chief, Schizophrenia Division, CAMHVerified email at utoronto.ca
Pierre sokoloffBiodol TherapeuticsVerified email at biodol.eu
Justin MathesonPostdoctoral Researcher, Centre for Addiction and Mental HealthVerified email at camh.ca
Peter SelbyUniversity of Toronto, Centre for addiction and Mental healthVerified email at camh.ca
R TyndaleCAMH and University of TorontoVerified email at utoronto.ca
Jose M. TrigoBoston PharmaceuticalsVerified email at bostonpharmaceuticals.com
Abhi Pushparaj+ROI Regulatory AdvisoryVerified email at utoronto.ca
Didier Jutras-AswadUniversité de MontréalVerified email at umontreal.ca
Christian HendershotUniversity of Southern CaliforniaVerified email at usc.edu
Christine M. WickensCentre for Addiction and Mental HealthVerified email at camh.ca
James L KennedyProfessor of Psychiatry, Centre for Addiction and Mental Health, University of TorontoVerified email at camh.ca
Islam GamaleddinCentre for Addiction and Mental Health - University of TorontoVerified email at utoronto.ca
Zuzana JustinovaNational Institute on Drug AbuseVerified email at intra.nida.nih.gov
Benedikt FischerVerified email at sfu.ca
Zafiris J. DaskalakisDepartment of Psychiatry, UC San DiegoVerified email at health.ucsd.edu
Clement C. ZaiUniversity of Toronto and Centre for Addiction and Mental HealthVerified email at camh.ca
Alan A WilsonEmeritus Scientist, Centre for Addiction and Mental HealthVerified email at camhpet.ca
Laurie ZawertailoSenior Scientist, CAMHVerified email at camh.ca
Andriy V. SamokhvalovAssociate Professor of Psychiatry, University of TorontoVerified email at drsamshealth.com
Follow
Bernard Le Foll
University of Toronto; Centre for Addiction and Mental Health; Waypoint Centre for Mental Health
Verified email at camh.ca